IP Library Granted Patent US 10,900,017
Granted Patent B2
US 10,900,017 · App. 16/706,372 · Granted Jan 26, 2021

Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof

Inventors: Robert Lane Smith (Palo Alto, CA); Laurence J. B. Tarrant (Northhampton, MA); Akihiko Kusanagi (Brookline, MA); Hans P. I. Claesson (Wayland, MA)
Assignee: HISTOGENICS CORPORATION
C12N5/0068A61L27/24A61L27/3817A61L27/3843A61L27/56C12N5/0655A61F2/08A61F2/30756A61F2/3872A61F2002/30062A61F2210/0004A61F2310/00365A61L2400/18A61L2430/06A61L2430/10C12N2533/54C12N2535/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,900,017
App. No.
16/706,372
Granted
Jan 26, 2021
Kind
B2
Abstract

A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.

Claims (29)

1. An implant comprising:

a porous body comprising collagen, wherein the body has a top surface, an opposed basal surface, and a plurality of pores of substantially uniform pore size and orientation extending from the top surface to the basal surface.

2. The implant of claim 1 , wherein about 95% of the pores have a diameter of about 200 plus or minus 100 microns.

3. The implant of claim 1 , wherein about 95% of the pores have a diameter of about 200 plus or minus 50 microns.

4. The implant of claim 1 , wherein about 98% of the pores have a diameter of about 200 plus or minus 100 microns.

5. The implant of claim 1 , wherein about 98% of the pores have a diameter of about 200 plus or minus 50 microns.

6. The implant of claim 1 , wherein the collagen comprises one selected from the group consisting of type I collagen, type II collagen, and type IV collagen.

7. The implant of claim 1 , wherein the collagen is type I collagen.

8. The implant of claim 1 , further comprising a gel disposed within the pores.

9. The implant of claim 8 , wherein the gel is a sol-gel.

10. The implant of claim 9 , wherein the sol-gel has a sol-to-gel transition temperature of about 37 degrees C.

11. The implant of claim 8 , wherein the gel comprises a plurality of chondrocytes suspended therein.

12. The implant of claim 11 , wherein the chondrocytes include human articular chondrocytes.

13. The implant of claim 8 , wherein the gel comprises a collagen solution.

14. The implant of claim 11 , wherein the porous body and the gel are in the form of a wafer-like construct having a diameter from about 4 mm to about 25 mm and a thickness from about 0.5 mm to about 5 mm.

15. The implant of claim 14 , wherein the wafer-like construct has been cut from a composition cylindrical or rectangular block structure.

16. The implant of claim 8 , wherein the gel further includes a plurality of chondrocytes suspended therein.

17. The implant of claim 16 , wherein the gel is a sol-gel that gels at a body temperature.

18. The implant of claim 16 , wherein the chondrocytes are suspended within the collagen solution at a seeding density of about 75,000-300,000 chondrocytes per 25 microliters of the collagen solution.

19. The implant of claim 14 , wherein the sol-gel is a collagen solution comprising type I collagen.

20. A cartilage implant comprising:

a porous body comprising type I collagen disposed between a top surface and an opposed basal surface of the porous body, the porous body having a plurality of pores of substantially uniform pore size and orientation extending from the top surface to the basal surface, wherein about 95% of the pores have a diameter of about 200 plus or minus 100 microns;

a sol-gel that gels at a body temperature disposed within the pores; and

a plurality of chondrocytes suspended within the sol-gel.

21. The implant of claim 20 , wherein:

the chondrocytes include human articular chondrocytes;

the porous body and the gel are in the form of a wafer-like construct having a diameter from about 4 mm to about 25 mm and a thickness from about 0.5 mm to about 5 mm;

the sol-gel is a collagen solution comprising type I collagen; and

the chondrocytes are suspended within the collagen solution at a seeding density of about 75,000-300,000 chondrocytes per 25 microliters of the collagen solution.

Assignments (2)
CHANGE OF NAME Recorded Jun 29, 2022
From: HISTOGENICS CORPORATION
To: OCUGEN, INC.
Reel/Frame 060541/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2019
From: SMITH, ROBERT LANE; TARRANT, LAURENCE J.B.; KUSANAGI, AKIHIKO; CLAESSON, HANS P.I.
To: HISTOGENICS CORPORATION
Reel/Frame 051214/0133 →